Research Article
Variability in the Management of Superficial Venous Thrombophlebitis across Practitioners Based in North America and the Global Community
Table 5
Follow-up trends among practitioners in North America and the global community.
| Variable | North America, (%) | Global community, (%) | value |
| Follow-up of patients with acute saphenous thrombophlebitis | | | <0.005 | <1 week | 142 (38.9%) | 21 (17.2%) | | 1–4 weeks | 102 (28.0%) | 24 (19.7%) | | 1–3 months | 30 (8.2%) | 15 (12.3%) | | Only if symptoms worsen | 25 (6.9%) | 25 (20.5%) | | Other/no answer | 66 (18.1%) | 37 (30.3%) | |
| Follow-up for patients with SVT of superficial tributaries/varicosities besides saphenous vein | | | 0.27 | <1 week | 72 (19.7%) | 26 (21.3%) | | 1–4 weeks | 64 (17.5%) | 20 (16.4%) | | 1–3 months | 51 (14.0%) | 21 (17.2%) | | Only if symptoms worsen | 54 (14.8%) | 22 (18.0%) | | Other/no answer | 124 (34.0%) | 33 (27.1%) | |
| Treating patients with SVT after successful GSV ablation | | | <0.005 | Compression and NSAIDs | 225 (61.6%) | 39 (32.0%) | | Immediate clot drainage | 98 (26.9%) | 36 (29.5%) | | Other/no answer | 42 (11.5%) | 47 (38.5%) | |
| Initially treating patients with trapped blood after sclerotherapy | | | <0.005 | Compression and NSAIDs | 123 (33.7%) | 37 (30.3%) | | Immediate clot drainage | 198 (54.3%) | 42 (34.4%) | | Other/no answer | 43 (12.1%) | 43 (35.3%) | |
|
|